Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37578,1527,1.04 [0.91-1.19],0.5351132469138022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37008,360,1.01 [0.76-1.34],0.9424081666036548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,40977,275,1.00 [0.73-1.37],0.9996984051412356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28312,1281,1.13 [0.97-1.30],0.1147253988079128
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,40886,184,1.13 [0.79-1.62],0.4911542878255118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38349,145,1.00 [0.64-1.54],0.984619891637492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",42935,182,1.14 [0.79-1.63],0.4873488437824593
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42942,124,1.32 [0.89-1.95],0.1632221194510273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37460,94,1.30 [0.82-2.07],0.262102869870869
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,41616,200,0.95 [0.65-1.39],0.7841449528604839
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,41544,128,0.93 [0.57-1.51],0.76530754596263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43060,117,0.97 [0.60-1.59],0.9158047018318286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43063,143,1.28 [0.88-1.87],0.1963393552332596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43053,133,1.30 [0.89-1.92],0.1751361987831841
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,42503,93,1.18 [0.72-1.94],0.5054032077501559
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41063,682,1.00 [0.82-1.23],0.9992786345857764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,40617,236,0.79 [0.53-1.16],0.2256481968894813
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,40850,469,0.98 [0.76-1.25],0.8481654039310557
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34572,109,1.08 [0.68-1.73],0.7435335356278949
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34553,90,0.74 [0.40-1.39],0.3564305597905152
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",34899,436,0.92 [0.71-1.20],0.5585677943269987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",34912,449,0.97 [0.75-1.24],0.7845100983188004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.98 [0.78-1.22],0.8365322704840876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15614,190,0.93 [0.63-1.39],0.7388394234562542
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34552,89,0.91 [0.50-1.64],0.7438039900767018
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38555,1300,0.95 [0.82-1.11],0.5056767347338655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",40932,566,1.03 [0.83-1.29],0.7706424728852675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42279,205,1.26 [0.92-1.72],0.155594243470743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43205,191,0.91 [0.61-1.36],0.6505807364295741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,42739,117,1.13 [0.72-1.77],0.6010395676469855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43209,110,0.87 [0.51-1.49],0.6234851891885489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,43295,82,0.70 [0.35-1.37],0.2944519544628183
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,42834,504,1.00 [0.79-1.27],0.986400163513113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43216,191,1.11 [0.78-1.59],0.5677679421729203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43225,152,0.94 [0.60-1.46],0.7686793172630162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43121,90,1.08 [0.64-1.82],0.7661280043050968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",43126,89,1.08 [0.64-1.83],0.7619302366105184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,42974,327,0.81 [0.59-1.12],0.2046945697412417
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43240,147,0.92 [0.59-1.44],0.70758642861414
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,43051,306,0.71 [0.50-1.01],0.05337846483833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,1.03 [0.64-1.64],0.9134714827141844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,1.05 [0.88-1.25],0.5657254953172335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41185,323,0.92 [0.68-1.25],0.5894848964322315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,40639,565,1.03 [0.83-1.28],0.7627581205829216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,40639,565,1.03 [0.83-1.28],0.7627581205829216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37511,740,0.99 [0.81-1.21],0.9281505866422078
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42366,119,0.61 [0.34-1.10],0.0985718689153419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,42799,130,1.31 [0.89-1.93],0.1711710428747054
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35013,1899,0.97 [0.85-1.11],0.6567779875433812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,40788,900,0.86 [0.71-1.04],0.124719471589384
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39381,200,1.10 [0.77-1.57],0.5996751252493281
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41302,187,1.28 [0.90-1.81],0.1632290650744938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39361,180,1.14 [0.79-1.65],0.4703655561051256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40080,899,1.02 [0.85-1.23],0.7999740997791186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40054,873,1.02 [0.84-1.23],0.838665789667032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40108,295,1.26 [0.91-1.73],0.1615657004272378
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40111,292,1.26 [0.91-1.74],0.1590696115406616
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,34729,1615,0.97 [0.84-1.12],0.6846861586292672
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33320,206,1.03 [0.72-1.49],0.8640170366047341
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,34612,1498,0.95 [0.82-1.10],0.5114557709473242
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33195,81,1.13 [0.66-1.94],0.6504778697986535
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33243,129,0.97 [0.60-1.55],0.895102000739912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,36680,1088,0.98 [0.83-1.16],0.8340560762320608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",35986,394,0.94 [0.70-1.27],0.6938051266091765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",42625,290,0.94 [0.67-1.32],0.7176301866492953
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",42726,211,0.94 [0.63-1.40],0.7605120191700302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40302,98,1.06 [0.62-1.79],0.8365241373755663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43132,98,1.04 [0.61-1.78],0.8774113616597805
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",35690,98,1.05 [0.62-1.78],0.8465281297582808
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,40324,120,1.00 [0.60-1.65],0.9907511359134622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,40224,104,1.12 [0.65-1.94],0.687188901319354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35690,98,0.83 [0.46-1.52],0.5476180012353639
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36117,525,1.03 [0.81-1.29],0.8288569399331696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression,40629,462,1.01 [0.79-1.29],0.9506188087132876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,35720,402,0.98 [0.75-1.28],0.8816907922264599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",35804,212,0.80 [0.53-1.19],0.2697116822105523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,40831,110,0.60 [0.33-1.12],0.1078004075351154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,37253,2491,0.98 [0.88-1.10],0.7401206758791792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,33844,238,1.01 [0.72-1.41],0.9480372345198635
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43038,187,0.94 [0.64-1.40],0.7753468172072057
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41087,800,0.96 [0.79-1.16],0.6711872143478306
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,40536,249,0.79 [0.54-1.16],0.2289696091499199
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,40422,135,1.17 [0.78-1.75],0.4407091571618095
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",42784,120,1.23 [0.81-1.85],0.329108245231721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,41929,130,1.01 [0.64-1.60],0.9649505087440404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,40564,277,0.99 [0.71-1.39],0.9700040203791258
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,42343,211,0.97 [0.66-1.43],0.880171418542407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41332,1115,1.00 [0.85-1.17],0.9998269624524782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40424,207,1.06 [0.74-1.51],0.7612747038497953
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,40859,642,1.03 [0.84-1.27],0.7521942271190311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,42819,140,0.92 [0.58-1.47],0.7296781114590565
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,42777,98,0.95 [0.55-1.64],0.866949354036384
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,42466,203,0.90 [0.61-1.33],0.6039410070663314
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42178,629,1.18 [0.98-1.43],0.0777323235847298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,41910,361,1.08 [0.83-1.41],0.5471871615200383
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41680,131,1.54 [1.12-2.14],0.0085410262342508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41748,199,1.08 [0.76-1.55],0.6524889531283526
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41677,128,1.21 [0.81-1.82],0.3565950129739997
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37295,262,1.31 [1.00-1.73],0.0507145695325648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,37708,675,0.98 [0.79-1.21],0.835746211617566
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,41602,343,1.01 [0.76-1.34],0.9712598006979856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,42726,68,1.30 [0.75-2.25],0.3551819840962685
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3665,68,1.34 [0.76-2.34],0.3123939002875363
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39129,68,1.30 [0.75-2.25],0.3471062859007856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42143,155,1.15 [0.78-1.69],0.4740665704171838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42069,81,1.07 [0.61-1.87],0.8069368052623489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42119,140,1.17 [0.79-1.75],0.4322875494127669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42374,170,0.96 [0.63-1.45],0.8435890346702006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43106,221,0.98 [0.68-1.40],0.9024295955427576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,41879,179,0.91 [0.60-1.38],0.6727908037905234
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30623,5403,0.99 [0.91-1.08],0.9062964617591224
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42248,116,1.08 [0.68-1.72],0.7530906673314518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",32287,3716,0.97 [0.88-1.07],0.5725547364131494
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,32326,3755,0.98 [0.89-1.08],0.6408101920015333
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28660,89,1.16 [0.70-1.90],0.5669342717635322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",39638,1957,1.04 [0.92-1.18],0.5330025388943743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,38852,1171,1.05 [0.90-1.23],0.5534485742123119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41534,387,0.94 [0.71-1.25],0.6652390646091859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,41921,774,0.91 [0.74-1.12],0.3611852874627669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43060,162,0.74 [0.46-1.20],0.227848846015148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38168,487,0.88 [0.68-1.15],0.3570272006465637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39192,1539,1.01 [0.88-1.17],0.8626650371936693
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,41889,188,1.11 [0.78-1.59],0.5683201571629277
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42091,395,1.09 [0.85-1.40],0.514422017897298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,41866,165,1.26 [0.89-1.78],0.1997411963954278
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,41868,167,1.25 [0.88-1.77],0.211891244904816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28729,158,1.25 [0.89-1.75],0.2006066006370385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36044,101,1.27 [0.82-1.96],0.2879923430972154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,36146,203,1.22 [0.89-1.69],0.219144862308813
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,23957,191,0.85 [0.57-1.28],0.447579127591505
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24499,733,1.02 [0.84-1.24],0.8478105015874176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36057,114,0.58 [0.31-1.06],0.0782293293339058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36102,159,1.42 [1.04-1.95],0.0293563113313105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",41536,347,1.13 [0.86-1.48],0.3718078105545246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",41797,253,0.69 [0.47-1.02],0.0650061688364391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",41855,213,0.65 [0.42-1.01],0.0566202227929079
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",41984,185,0.67 [0.42-1.06],0.0872315695264223
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41292,127,1.40 [0.96-2.04],0.0830750349659016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41386,221,1.19 [0.86-1.65],0.2893799401694239
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),40832,244,1.06 [0.77-1.47],0.7132043804994543
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,40793,205,0.99 [0.68-1.44],0.946543788606642
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",42916,197,0.95 [0.65-1.40],0.8058178788113936
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,41395,807,1.08 [0.90-1.28],0.4236379553551181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,41344,135,1.11 [0.73-1.69],0.617284126476653
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34587,3492,0.97 [0.88-1.07],0.5160337431936971
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,42963,186,1.09 [0.75-1.58],0.6512598207579032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,40229,384,1.00 [0.76-1.32],0.9771128464382806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40178,333,0.99 [0.74-1.33],0.9434176669178604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,41734,436,0.87 [0.66-1.15],0.3321149757648961
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,41727,429,0.89 [0.68-1.17],0.4159810460913259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,41914,1031,0.84 [0.70-1.00],0.0550869763956416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41047,164,0.62 [0.38-1.02],0.0624522698059032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,41093,210,0.96 [0.66-1.39],0.8166238566239048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41534,651,0.87 [0.69-1.09],0.2129903367413732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41189,306,0.96 [0.70-1.30],0.7775531105120275
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,19947,104,0.93 [0.55-1.58],0.8007046065701677
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,38635,1709,1.05 [0.92-1.19],0.4825499247857888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,41317,297,1.02 [0.74-1.41],0.8933593308402846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41357,337,0.97 [0.71-1.32],0.8519984524379651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41357,337,0.97 [0.71-1.32],0.8519984524379651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40334,1405,1.05 [0.91-1.20],0.534131454434832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Asthma,30929,1405,1.05 [0.91-1.21],0.5167227043863286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30487,1405,1.05 [0.91-1.21],0.5001173708933542
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",30907,1383,1.04 [0.91-1.20],0.5536814278645016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,42643,172,1.35 [0.97-1.87],0.0737615884092674
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,40731,134,1.41 [0.98-2.01],0.0631236022719342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",42777,134,1.40 [0.98-2.00],0.0682970736148529
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,40718,121,1.26 [0.83-1.91],0.2833334149959845
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,39809,182,0.97 [0.65-1.44],0.8648641403724135
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,40026,399,0.94 [0.71-1.24],0.6718531948637315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41164,185,0.86 [0.57-1.32],0.4946738855037403
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29496,9772,1.00 [0.93-1.07],0.9340858444265558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42396,705,0.81 [0.65-1.01],0.0581180386972459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43231,150,0.57 [0.33-0.97],0.0367469534834522
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,43237,139,0.50 [0.28-0.88],0.0157234760448616
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,41877,186,0.81 [0.53-1.25],0.3409156138749216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41856,165,0.75 [0.47-1.19],0.2228452040765429
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43214,167,0.59 [0.36-0.97],0.0385353501619689
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41846,155,0.89 [0.57-1.40],0.6200302097034366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41414,129,0.87 [0.53-1.43],0.5776174300390616
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43094,89,0.94 [0.53-1.69],0.8446950603381405
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,32977,449,0.99 [0.76-1.28],0.9193485334370792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36170,3642,1.04 [0.95-1.14],0.4389698076576893
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,33099,571,1.04 [0.83-1.29],0.7505343337277149
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,33716,1188,1.02 [0.88-1.20],0.7572900362787867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,32654,126,0.90 [0.55-1.50],0.6981129854551664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32882,354,0.86 [0.63-1.17],0.3219764202454113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32624,96,0.89 [0.50-1.59],0.6922088219693903
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,32772,244,0.85 [0.59-1.24],0.4020748457941113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,32741,213,1.23 [0.89-1.72],0.2154668815381039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43062,150,1.11 [0.74-1.68],0.614704190026964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,32738,210,0.85 [0.57-1.28],0.4398514489082371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),33889,1361,1.14 [0.99-1.31],0.0598224958610793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43017,216,0.70 [0.46-1.07],0.0986527171939633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33269,741,0.98 [0.81-1.20],0.8750585247942015
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,32808,280,1.02 [0.75-1.40],0.8902880962515417
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43004,273,1.17 [0.87-1.57],0.3048771271217367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,42976,175,0.67 [0.42-1.08],0.0994828385178469
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,37951,2726,0.92 [0.82-1.03],0.1355313378045036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,36235,1010,0.89 [0.74-1.07],0.204049013826027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,35429,204,0.99 [0.67-1.45],0.9445477388379432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,35388,163,1.08 [0.72-1.60],0.7206887113874372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,36681,1456,0.92 [0.79-1.07],0.2620103185559298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,41648,1285,1.03 [0.89-1.19],0.732525022662855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,33950,3371,1.09 [1.00-1.20],0.0625174497125494
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42721,102,0.94 [0.55-1.61],0.8207222828067549
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43177,139,0.91 [0.57-1.46],0.7078620948066867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,40502,139,0.91 [0.57-1.46],0.7083024568997422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40468,105,1.09 [0.67-1.78],0.7337648935894464
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43060,234,1.01 [0.72-1.43],0.9424219259065691
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,40597,234,1.01 [0.72-1.43],0.9406508547453606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40571,208,1.01 [0.70-1.45],0.9677356466543844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41407,1044,1.04 [0.88-1.22],0.6601931187163473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41395,1032,1.04 [0.89-1.23],0.5949198001811864
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,30747,168,0.93 [0.61-1.42],0.7412529468395213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,42508,168,0.92 [0.60-1.41],0.6987698174622703
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",30691,112,0.77 [0.43-1.35],0.3557690433896369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31580,1001,1.07 [0.91-1.26],0.4196240081530811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,30858,279,1.04 [0.77-1.41],0.8013751929262416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31051,472,1.16 [0.93-1.44],0.1960566843128154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,40600,424,1.12 [0.89-1.42],0.3425724119927005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,42538,148,1.10 [0.73-1.65],0.6442872803072903
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30829,250,1.13 [0.83-1.55],0.4371382398416508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30704,125,1.09 [0.69-1.72],0.7090971178108518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32068,1489,1.06 [0.93-1.22],0.3680321157098122
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,31047,468,1.16 [0.93-1.44],0.1973048387166248
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42515,125,1.01 [0.63-1.60],0.978628237431969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,41899,203,1.30 [0.95-1.77],0.1059692997956111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,41808,112,1.23 [0.79-1.91],0.353375384735643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",40960,1035,0.95 [0.80-1.13],0.5699085746672639
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,40754,829,0.86 [0.71-1.05],0.1464751565719508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,40090,165,1.41 [1.04-1.92],0.0280663383901065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40003,78,0.56 [0.26-1.17],0.1227506661516018
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40036,111,0.72 [0.40-1.29],0.270377536888995
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),42982,111,0.72 [0.40-1.29],0.2640976165739237
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,40952,519,1.26 [1.03-1.54],0.0246813703754229
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40547,114,1.29 [0.86-1.94],0.2161699359068278
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,40528,95,1.20 [0.75-1.92],0.4517328634332331
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40514,81,1.49 [0.98-2.28],0.0635402760287503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,40767,334,1.20 [0.92-1.56],0.1728020576519515
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,40755,322,1.17 [0.89-1.53],0.2648415225303205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38025,2632,1.06 [0.96-1.18],0.2494169865377689
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,42524,181,0.89 [0.59-1.35],0.5833366037668171
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42585,774,1.05 [0.87-1.26],0.6187640927499078
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,40647,972,1.04 [0.88-1.23],0.6540856557654999
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,41751,675,1.16 [0.96-1.40],0.1292430843186645
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41229,153,1.22 [0.83-1.80],0.3082522566611371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41504,428,1.10 [0.86-1.41],0.4420886789479801
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,42805,153,1.48 [1.08-2.03],0.0158564695871249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,42769,117,1.50 [1.04-2.15],0.0279589049116197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42742,90,1.23 [0.75-2.01],0.4123193632751458
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41911,100,0.48 [0.24-0.94],0.0329432624577056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42426,615,1.06 [0.86-1.30],0.6012405537911114
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,39832,157,0.96 [0.62-1.47],0.8363711955816173
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39840,165,0.92 [0.60-1.40],0.69105374583078
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39803,128,0.80 [0.48-1.34],0.3899164441902063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40043,368,1.00 [0.76-1.32],0.9866553669308562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40008,333,1.01 [0.76-1.35],0.9314802169669648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31206,6718,1.00 [0.93-1.08],0.9689411768044734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,33921,3905,0.98 [0.90-1.08],0.7222903960624684
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,38997,2045,1.11 [0.99-1.24],0.0785678259605979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30278,262,1.01 [0.73-1.39],0.94938431633513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,30784,768,1.06 [0.88-1.28],0.521802143601932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",42570,251,1.02 [0.74-1.42],0.8831343543162599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,42586,227,1.05 [0.75-1.48],0.7566855337320524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,31942,1926,1.01 [0.89-1.14],0.9177745935292888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36260,1926,1.00 [0.89-1.14],0.9417328672904186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30130,114,1.41 [0.95-2.11],0.0901770691570229
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42347,110,1.44 [0.97-2.15],0.070843502654724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30373,357,0.93 [0.70-1.25],0.6488558044382273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30133,117,1.07 [0.68-1.70],0.7643316837437057
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30500,484,1.05 [0.84-1.33],0.6602717135976249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43000,244,0.94 [0.66-1.33],0.7261443622511818
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,30901,885,1.06 [0.89-1.26],0.5398431240323918
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30663,647,0.87 [0.69-1.09],0.2198633922393056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32195,2179,0.95 [0.84-1.07],0.3700721158043236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30136,120,0.87 [0.52-1.45],0.5838661316611335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30410,394,0.94 [0.72-1.23],0.6605374584502006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30106,90,0.58 [0.29-1.15],0.1198404167697027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30117,101,1.10 [0.68-1.78],0.697818211559847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,30831,815,1.00 [0.83-1.21],0.9815690907085772
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,30722,706,0.96 [0.78-1.18],0.6934874759776432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33487,470,1.02 [0.80-1.29],0.9017908535711576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42322,242,1.00 [0.71-1.39],0.9811353139814816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42177,97,0.93 [0.54-1.62],0.8084999901436213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37450,111,1.01 [0.62-1.65],0.959312559165342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,37853,514,0.98 [0.77-1.24],0.8656256603656497
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,38915,1576,0.97 [0.84-1.11],0.6183292490278673
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,37666,327,0.93 [0.68-1.26],0.6177891123622699
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37485,146,1.01 [0.65-1.56],0.9594997678525712
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",38586,1247,0.97 [0.83-1.13],0.6618014770661664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37424,85,1.32 [0.83-2.11],0.2443418654586598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,37745,406,0.81 [0.61-1.09],0.160379939019697
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37512,173,0.84 [0.54-1.30],0.4415148885150671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37466,127,1.20 [0.80-1.81],0.380577538554523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37567,228,1.03 [0.73-1.45],0.8791492895363299
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37447,108,1.05 [0.64-1.72],0.8369112182018488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,37868,529,0.76 [0.58-0.99],0.0384579700754506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37482,530,1.11 [0.89-1.38],0.3406808503354728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37066,114,1.30 [0.85-1.97],0.2221709122379432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37102,150,1.11 [0.74-1.66],0.630338187716145
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37124,172,0.99 [0.66-1.48],0.9713469725647258
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37040,88,1.18 [0.71-1.98],0.527589103286881
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37145,193,1.11 [0.77-1.60],0.5649009298894302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37126,174,1.09 [0.74-1.61],0.6482462235262474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37384,432,0.96 [0.73-1.25],0.7463924290638706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37046,94,1.25 [0.79-2.00],0.3424450122942919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37078,126,0.84 [0.49-1.42],0.5059133840447716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37158,206,1.14 [0.81-1.61],0.4389302964668404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37060,108,1.21 [0.77-1.89],0.4176532351595527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",37716,764,1.11 [0.93-1.34],0.2513047561463516
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37243,291,1.22 [0.93-1.61],0.1482092862683678
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37368,416,1.02 [0.79-1.33],0.8625164439206483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40133,294,0.79 [0.56-1.11],0.1802501070522301
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40489,650,0.94 [0.76-1.16],0.546683592294769
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,39919,80,1.30 [0.80-2.13],0.2870147381241061
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,39933,94,1.09 [0.65-1.81],0.749828136825271
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40006,167,0.81 [0.52-1.27],0.3578460641183442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34488,7171,1.01 [0.94-1.08],0.8835968227258035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17117,1048,0.95 [0.80-1.14],0.6054335553908153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39103,357,1.34 [1.06-1.69],0.0131413066752356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,38851,105,1.54 [1.07-2.23],0.0208679056998148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,39326,74,1.11 [0.62-2.01],0.7184353143392489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39328,76,1.63 [1.08-2.45],0.0192860263031297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39344,92,1.16 [0.70-1.92],0.5664002195309006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42660,402,1.06 [0.82-1.37],0.6634887920388655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,42579,105,0.86 [0.49-1.50],0.5927871395104471
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42548,290,1.15 [0.86-1.53],0.3394091472039177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42402,144,1.17 [0.78-1.75],0.4487862158462061
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,39621,1764,0.95 [0.83-1.09],0.4615883601457613
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38008,151,1.29 [0.90-1.84],0.1600781619665428
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37991,134,0.89 [0.55-1.45],0.6400926504485125
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38308,451,0.99 [0.77-1.27],0.9161409284744002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38050,193,0.62 [0.39-0.98],0.0425825810855366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39018,1161,1.00 [0.85-1.16],0.9677821363442228
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16531,462,0.89 [0.68-1.17],0.4046721669702652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16158,89,1.29 [0.82-2.05],0.2697710085372647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16156,87,1.05 [0.60-1.85],0.8545473998171853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16201,132,0.58 [0.33-1.03],0.0635980211534876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16201,132,1.16 [0.77-1.77],0.4758351420460784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16240,171,0.95 [0.62-1.45],0.8024996027489302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.06 [0.83-1.35],0.6675021910690335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,1.44 [1.02-2.03],0.0381010686576153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.18 [0.81-1.73],0.3905525779297079
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.66 [0.36-1.22],0.1821809007931486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,0.95 [0.74-1.21],0.6795211437937114
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,1.24 [0.82-1.86],0.3049818369559801
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.06 [0.75-1.49],0.740420211406791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.01 [0.92-1.11],0.7869232904665762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,1.01 [0.75-1.37],0.9422583375699508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,1.01 [0.57-1.78],0.9805744295820442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,1.07 [0.70-1.65],0.7515111578548117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,0.93 [0.75-1.15],0.5160685656151713
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.89 [0.66-1.20],0.4535845520445095
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,1.03 [0.86-1.23],0.7733630312756711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,0.71 [0.49-1.03],0.0711251503057935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,0.89 [0.67-1.19],0.4453361229023029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.14 [0.78-1.67],0.5019414501177422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.18 [0.87-1.62],0.2884965286198659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.19 [0.87-1.63],0.2853493886677483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.13 [0.72-1.77],0.5858636765727914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.22 [0.81-1.84],0.332027022127256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.07 [0.68-1.68],0.7803675469339291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,0.65 [0.35-1.21],0.1747039122289276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,0.75 [0.44-1.30],0.3073066441270067
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,1.13 [0.89-1.44],0.3270634144520474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,1.14 [0.98-1.32],0.0946526149532419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,1.15 [0.96-1.38],0.1198626288418227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,1.05 [0.72-1.55],0.7890223151699762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,1.30 [1.04-1.62],0.022442224549974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,0.91 [0.65-1.28],0.5926575975355489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.01 [0.84-1.23],0.8892303861431937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.73 [0.39-1.38],0.3311203618694509
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,0.71 [0.37-1.38],0.3117116540803512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,1.03 [0.83-1.26],0.8105757848920587
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,1.00 [0.83-1.21],0.9965553001616696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,0.79 [0.59-1.08],0.1354642742197793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,1.10 [0.68-1.76],0.7015934756384037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,0.51 [0.30-0.87],0.0136502498459943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,0.86 [0.52-1.41],0.5477851528844431
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,1.08 [0.72-1.64],0.6978258831032671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,1.07 [0.71-1.63],0.7371904474938626
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,1.02 [0.77-1.35],0.8882923928213056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.83 [0.47-1.45],0.5061314022211558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,1.10 [0.78-1.56],0.5877392184249757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,0.66 [0.37-1.17],0.1546647071388622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,1.07 [0.72-1.59],0.7362337393275872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,1.32 [0.97-1.80],0.0746758448786297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.93 [0.56-1.52],0.7607497874705375
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,1.15 [0.72-1.82],0.565550993317895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,1.04 [0.65-1.66],0.8748017786679121
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.90 [0.59-1.37],0.6350017786516724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,1.01 [0.76-1.35],0.944866025193264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,1.14 [0.91-1.43],0.2497066115414389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,1.10 [0.73-1.66],0.6392811071269354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,1.25 [0.81-1.94],0.3088611224267933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,1.12 [0.64-1.94],0.6901949977688644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,0.76 [0.53-1.09],0.1368128506110555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,0.93 [0.64-1.35],0.7048951464590203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,0.76 [0.50-1.15],0.1913584685139633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,0.79 [0.53-1.20],0.2733693454946398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",42634,103,1.23 [0.79-1.93],0.3632272812620589
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,39114,994,0.94 [0.79-1.12],0.4678468134981515
